News
Pandemic poses short- and long-term risks to babies, especially boys
- Author:
- Liz Szabo
- Kaiser Health News
Publish date: December 22, 2021
For fetuses exposed to COVID, the greatest danger is usually not the coronavirus itself, but the mother’s immune system.
News
Pricey precision medicine often financially toxic for cancer patients
- Author:
- Liz Szabo
Publish date: November 1, 2018
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.
News
Never too late to operate? Surgery near end of life is common, costly
- Author:
- Liz Szabo
- Kaiser Health News
Publish date: March 1, 2018
Nearly 1 in 3 Medicare patients undergo an operation in their final year of life.
News
Cascade of costs could push new gene therapy above $1 million per patient
- Author:
- Liz Szabo
- Kaiser Health News
Publish date: October 17, 2017
Although Kymriah’s price tag has “shattered oncology drug-pricing norms,” Dr. Saltz said “the sticker price is just the starting point.”
News
‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost
- Author:
- Liz Szabo
- Kaiser Health News
Publish date: August 23, 2017
Novartis hasn’t announced a price for CTL019, but British health authorities have said a price of $649,000 for a one-time treatment would be...
News
As government-funded cancer research sags, scientists fear U.S. is ‘losing its edge’
- Author:
- Liz Szabo
Publish date: June 2, 2017
Less and less of the research presented at a prominent cancer conference is supported by the National Institutes of Health, a development that...